Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, synthesis and biological evaluation of novel naturally-inspired multifunctional molecules for the management of Alzheimer’s disease
Yash Pal Singh, Gullanki Naga Venkata Charan Tej, Amruta Pandey, et al.
European Journal of Medicinal Chemistry (2020) Vol. 198, pp. 112257-112257
Closed Access | Times Cited: 53

Showing 26-50 of 53 citing articles:

Design and synthesis of new indole drug candidates to treat Alzheimer’s disease and targeting neuro-inflammation using a multi-target-directed ligand (MTDL) strategy
Phoebe F. Lamie, Maha M. Abdel‐Fattah, John N. Philoppes
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 2660-2678
Open Access | Times Cited: 13
Nanotechnology-Based Drug Delivery Strategies to Repair the Mitochondrial Function in Neuroinflammatory and Neurodegenerative Diseases
Luis F. González, Lorenzo E. Bevilacqua, Rodrigo Naves
Pharmaceutics (2021) Vol. 13, Iss. 12, pp. 2055-2055
Open Access | Times Cited: 15
Design, Synthesis, and biological evaluation of pyrazolo-benzothiazole derivatives as a potential therapeutic agent for the treatment of Alzheimer’s disease
Harish Kumar, Anju Goyal, Navneet Kumar, et al.
Medicinal Chemistry Research (2022) Vol. 31, Iss. 11, pp. 1931-1947
Closed Access | Times Cited: 9
Extraction, isolation, synthesis, and biological evaluation of novel piperic acid derivatives for the treatment of Alzheimer’s disease
Jitendra Kumar, Gauri Shankar, Sunil Kumar, et al.
Molecular Diversity (2023) Vol. 28, Iss. 3, pp. 1439-1458
Closed Access | Times Cited: 4
Berberine derivatives as inhibitors of acetylcholinesterase: A systematic review
Yash Pal Singh, Harish Kumar
Chemical Biology & Drug Design (2023) Vol. 102, Iss. 6, pp. 1592-1603
Closed Access | Times Cited: 4
Amaryllidaceae Alkaloids of Norbelladine-Type as Inspiration for Development of Highly Selective Butyrylcholinesterase Inhibitors: Synthesis, Biological Activity Evaluation, and Docking Studies
Abdullah Al Mamun, Filip Pidaný, Daniela Hulcová, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8308-8308
Open Access | Times Cited: 11
Chemical Characterization and Biological Evaluation of New Cobalt(II) Complexes with Bioactive Ligands, 2-Picolinehydroxamic Acid and Reduced Schiff Base N-(2-Hydroxybenzyl)alanine, in Terms of DNA Binding and Antimicrobial Activity
Magdalena Woźniczka, Marta E. Lichawska, Manas Sutradhar, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 12, pp. 1254-1254
Open Access | Times Cited: 10
Acetylcholinesterase inhibition, molecular docking and ADME prediction studies of new dihydrofuran-piperazine hybrid compounds
Sait Sarı, Mehmet Yılmaz
Medicinal Chemistry Research (2021)
Closed Access | Times Cited: 7
Repurposing the in-house generated Alzheimer’s disease targeting molecules through computational and preliminary in-vitro studies for the management of SARS-coronavirus-2
Gourav Singh, Jobin Thomas, Sahil Wadhawa, et al.
Molecular Diversity (2023) Vol. 28, Iss. 5, pp. 2847-2862
Closed Access | Times Cited: 2
Derivatives of montanine-type alkaloids and their implication for the treatment of Alzheimer's disease: Synthesis, biological activity and in silico study
Negar Maafi, Filip Pidaný, Jana Maříková, et al.
Bioorganic & Medicinal Chemistry Letters (2021) Vol. 51, pp. 128374-128374
Closed Access | Times Cited: 6
Imino‐2H‐Chromene Based Derivatives as Potential Anti‐Alzheimer's Agents: Design, Synthesis, Biological Evaluation and in Silico Study
Mahshid Attarroshan, Omidreza Firuzi, Aida Iraji, et al.
Chemistry & Biodiversity (2021) Vol. 19, Iss. 1
Closed Access | Times Cited: 6
Design, synthesis and evaluation of sesamol-derived acetamides as dual inhibitors of monoamine oxidases and cholinesterases
Sandeep Kumar, Rangan Mitra, Senthil Raja Ayyannan
Medicinal Chemistry Research (2024) Vol. 33, Iss. 10, pp. 1974-1991
Closed Access
Discovery of novel substituted (Z)-N'-hydroxy-3-(3-phenylureido)benzimidamide derivatives as multifunctional molecules targeting pathological hallmarks of Alzheimer’s disease
Gauri Shankar, C. Praveen Kumar, M. K. Yadav, et al.
European Journal of Medicinal Chemistry (2024) Vol. 280, pp. 116959-116959
Closed Access
Discovery of novel thiosemicarbazone-acridine targeting butyrylcholinesterase with antioxidant, metal complexing and neuroprotector abilities as potential treatment of Alzheimer's disease: in vitro, in vivo, and in silico studies.
Gleyton Leonel Silva Sousa, Nathália Fonseca Nadur, Larissa A. Ferreira, et al.
European Journal of Medicinal Chemistry (2024) Vol. 281, pp. 117030-117030
Closed Access
Design, synthesis and evaluation of benzothiazole-derived phenyl thioacetamides as dual inhibitors of monoamine oxidases and cholinesterases
Sandeep Kumar, Rangan Mitra, Senthil Raja Ayyannan
Molecular Diversity (2024)
Closed Access
Design, synthesis and biological evaluation of novel piperic acid and benzylpiperazine hybrid molecules for improvement of memory impairment via cholinesterase inhibitory activity
Jitendra Kumar, Gauri Shankar, Sunil Kumar, et al.
Chemical Papers (2024) Vol. 79, Iss. 1, pp. 395-415
Closed Access
Discovery of novel hybrid tryptamine-rivastigmine molecules as potent AChE and BChE inhibitors exhibiting multifunctional properties for the management of Alzheimer’s disease
Gauri Shankar, Prabhat Kumar, Sanskriti Rai, et al.
European Journal of Medicinal Chemistry (2024) Vol. 283, pp. 117066-117066
Closed Access
Multi-target directed ligands inspired natural products as an effective approach for the treatment of complex chronic health disorders
Amera E. Shaaban, Ahmed R. Ali, Seif N. Ayyad, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 108075-108075
Closed Access
Phytochemistry and pharmacological advances of Ascophyllum nodosum in the management of human diseases: A comprehensive review
Brijesh Singh Chauhan, Yash Pal Singh
Phytomedicine Plus (2024), pp. 100718-100718
Open Access
Deoxyvasicinone hybrids in the management of Alzheimer's disease: Recent advances on manmade derivatives, pharmacological activities, and structure–activity relationship
A Gaur, Yash Pal Singh, Rajiv Sharma, et al.
Archiv der Pharmazie (2024) Vol. 358, Iss. 1
Closed Access
Neuroprotective Properties of Ferulic Acid in Preclinical Models of Alzheimer’s Disease: A Systematic Literature Review
Siyu Zhou, Xiaoyu Dong
Current Medicinal Chemistry (2022) Vol. 30, Iss. 24, pp. 2796-2811
Closed Access | Times Cited: 3
Synthesis and properties of the kojic acid dimer and its potential for the treatment of Alzheimer's disease
Xueyan Liu, Chuanyu Yu, Biling Su, et al.
RSC Medicinal Chemistry (2022) Vol. 14, Iss. 2, pp. 268-276
Open Access | Times Cited: 3
Alzheimer's disease therapeutics
Zhipei Sang, Ling Huang
Elsevier eBooks (2023), pp. 405-473
Closed Access | Times Cited: 1
Synthesis of phenylethanoid glycosides from acrylic esters of glucose and aryldiazonium salts via palladium-catalyzed cross-coupling reactions and evaluation of their anti-Alzheimer activity
Aswathi C. Narayanan, Rapelly Venkatesh, Shweta Singh, et al.
Carbohydrate Research (2023) Vol. 532, pp. 108920-108920
Closed Access | Times Cited: 1
Acetylcholinesterase Inhibition, Molecular Docking and ADME Prediction Studies of New Dihydrofuran-Piperazine Hybrid Compounds
Sait Sarı, Mehmet Yılmaz
Research Square (Research Square) (2021)
Open Access | Times Cited: 1

Scroll to top